TMEM106A

UniProt ID: Q96A25
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

TMEM106A is a type II single-pass transmembrane protein of the TMEM106 family, a paralog of the lysosomal protein TMEM106B. It localizes to the plasma membrane, with a short N-terminal cytoplasmic segment and a large C-terminal extracellular/lumenal domain. Its best-characterized role is as a positive regulator of macrophage activation: it promotes polarization toward a pro-inflammatory M1-like state through MAPK and NF-kB signaling, up-regulating surface CD80, CD86, CD69 and MHC class II and inducing pro-inflammatory mediators such as TNF, IL1B, IL6, CCL2 and nitric oxide. TMEM106A also behaves as a candidate tumor suppressor in several epithelial cancers, where it is frequently inactivated; restoring its expression inhibits proliferation, migration and invasion, induces apoptosis, and represses epithelial-mesenchymal transition and PI3K/AKT/NF-kB signaling. The specific biochemical activity of the protein at the membrane is not yet defined.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005765 lysosomal membrane
IBA
GO_REF:0000033
MARK AS OVER ANNOTATED
Summary: Lysosomal-membrane localization is very likely paralog-derived over-propagation from TMEM106B, not a bona fide location for TMEM106A.
Reason: This IBA sits on the TMEM106-family PAINT node (PANTHER:PTN002822587), whose lysosomal-membrane character derives from the extensively studied paralog TMEM106B, a well-characterized lysosomal membrane protein (the WITH/FROM even lists the human paralog UniProtKB:Q9NUM4 = TMEM106B). TMEM106A itself is curated by UniProt to the cell membrane (single-pass membrane protein, by similarity to mouse Q8VC04), and its documented function - macrophage activation via cell-surface signaling - operates at the plasma membrane. This is target-specific evidence that TMEM106A has diverged in localization from the family node, so lysosomal membrane should not be treated as a core location. Rather than assert an alternative id on an is_active_in row, flag it as over-annotated (paralog-derived); the plasma-membrane location is captured by the GO:0005886 annotations.
Propagation Review
Root cause: PROPAGATION BAD
Failure modes: WRONG ORTHOLOG OR PARALOG COMPARTMENT OR COMPLEX MISMATCH
Sources checked:
PANTHER:PTN002822587 Β· TMEM106 family node SUPPORTS SOURCE BUT NOT TARGET
Lysosomal-membrane character of the node derives from the lysosomal paralog TMEM106B; localization does not transfer to TMEM106A.
UniProtKB:Q9NUM4 Β· TMEM106B (human paralog) SUPPORTS SOURCE BUT NOT TARGET
Well-characterized lysosomal membrane protein; source of the node's lysosomal-membrane localization, not applicable to the cell-surface paralog TMEM106A.
GO:0042116 macrophage activation
IBA
GO_REF:0000033
ACCEPT
Summary: Macrophage activation is the conserved core function of the TMEM106 family and is well supported for TMEM106A.
Reason: This phylogenetically-inferred annotation reflects the conserved family role. TMEM106A activates macrophages / promotes M1 polarization via MAPK and NF-kB signaling (up-regulating CD80, CD86, CD69 and MHC class II and inducing TNF, IL1B, IL6, CCL2 and nitric oxide). The experimental grounding is in the mouse ortholog (UniProtKB:Q8VC04) and is carried to human TMEM106A by curator orthology transfer (UniProt FUNCTION, ECO:0000250|UniProtKB:Q8VC04) - not by a human macrophage assay in our cached literature. PMID:29131025 restates the point, but only in its BACKGROUND section as a summary of that prior mouse work; the study itself assays proliferation, migration and apoptosis in renal cancer cells and provides no independent macrophage-activation evidence. Retain as a core process on the orthology evidence, with the human-specific assay noted as an open gap.
Supporting Evidence:
PMID:29131025
TMEM106a is a conserved type II transmembrane protein which is a key factor to regulate macrophage activation.
GO:0005886 plasma membrane
IEA
GO_REF:0000120
ACCEPT
Summary: Plasma-membrane localization matches the UniProt-curated location for this type II single-pass membrane protein.
Reason: TMEM106A is a type II single-pass transmembrane protein (TM 95-115) curated by UniProt as "Cell membrane; Single-pass membrane protein" (by similarity to mouse Q8VC04, SL-0039). Its characterized function operates at the macrophage cell surface, consistent with plasma-membrane residence. Accept as a core location.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Uninformative high-throughput interactome annotation (HuRI Y2H); 'protein binding' conveys no specific molecular function.
Reason: This is a systematic yeast-two-hybrid screen from the human binary reference interactome (HuRI), not a focused study of TMEM106A biology. Per project guidelines the generic 'protein binding' (GO:0005515) term is uninformative about the actual molecular function, so the term is over-annotated. The WITH/FROM partner here is Q9BVX2 / TMEM106C, the same-family paralog also recovered by BioPlex AP-MS (PMID:33961781) - see that row for the family-heteromer reading. Not a core function; no informative replacement term can be justified from a high-throughput binary screen without direct validation.
GO:0005515 protein binding
IPI
PMID:33961781
Dual proteome-scale networks reveal cell-specific remodeling...
MARK AS OVER ANNOTATED
Summary: Uninformative high-throughput interactome annotation (BioPlex AP-MS); 'protein binding' conveys no specific molecular function.
Reason: This annotation derives from the proteome-scale BioPlex affinity-purification/MS network, a systematic interactome resource rather than a study of TMEM106A function. The generic 'protein binding' (GO:0005515) term is uninformative per project guidelines, so the term itself is over-annotated. The partner is not arbitrary, however. Q9BVX2 is TMEM106C, a same-family paralog, and it is the one interactor reproduced by two orthogonal methods - it appears in the WITH/FROM of both the HuRI Y2H row (PMID:32296183) and this BioPlex AP-MS row (PMID:33961781) - while UniProt records it at NbExp=5, the highest of the 11 listed interactions (all others are NbExp=3). A TMEM106A/TMEM106C family heteromer is therefore a real candidate worth testing, but 'protein binding' does not state it; a specific complex or heterodimerization term would need direct validation first.
GO:0035556 intracellular signal transduction
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Correct but general - captures the MAPK/NF-kB cascade TMEM106A drives; a broad parent of its more specific role.
Reason: TMEM106A signals through MAPK and NF-kB pathways to activate macrophages, so 'intracellular signal transduction' is accurate but is a high-level parent term that does not by itself capture the specific function. It is transferred by orthology from mouse Q8VC04. Keep as supporting/non-core context; the informative core is macrophage activation (GO:0042116).
GO:0042116 macrophage activation
IEA
GO_REF:0000107
ACCEPT
Summary: Orthology-transferred macrophage activation; consistent with the conserved core function.
Reason: Automatic orthology transfer from mouse Q8VC04, agreeing with the IBA and ISS macrophage-activation annotations and with the primary literature describing TMEM106A as a key regulator of macrophage activation (PMID:29131025). Retain as a core process.
GO:0035556 intracellular signal transduction
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: Correct but general - the MAPK/NF-kB signaling TMEM106A engages; a broad parent term, non-core.
Reason: Manual sequence-similarity transfer from mouse Q8VC04. Accurate in that TMEM106A acts through intracellular MAPK and NF-kB cascades, but this is a high-level parent that does not capture the specific function. Keep as supporting/non-core; the core process is macrophage activation.
GO:0005886 plasma membrane
ISS
GO_REF:0000024
ACCEPT
Summary: Plasma-membrane localization by curated sequence similarity to the mouse ortholog; matches UniProt.
Reason: Manual ISS transfer from mouse Q8VC04, consistent with the UniProt-curated "Cell membrane; Single-pass membrane protein" location and with TMEM106A's cell-surface function in macrophage activation. Accept as a core location.
GO:0042116 macrophage activation
ISS
GO_REF:0000024
ACCEPT
Summary: Curated sequence-similarity transfer of the conserved macrophage-activation function; core process.
Reason: Manual ISS transfer from the experimentally characterized mouse ortholog Q8VC04, the basis of the UniProt FUNCTION annotation, and concordant with the IBA/IEA macrophage-activation annotations and primary literature (PMID:29131025). Retain as the core biological process for TMEM106A.

Core Functions

Positive regulation of macrophage activation and M1-like polarization. As a plasma-membrane protein, TMEM106A engages MAPK and NF-kB signaling to drive a pro-inflammatory macrophage program, up-regulating co-stimulatory molecules (CD80, CD86, CD69) and MHC class II and inducing cytokines and nitric oxide. This is the conserved function of the TMEM106 family. The experimental grounding lies in the mouse ortholog Q8VC04; for human TMEM106A the evidence is orthology transfer (UniProt FUNCTION, ECO:0000250|UniProtKB:Q8VC04), which the GOA IBA/IEA/ISS rows all restate. The one human paper that repeats the claim (PMID:29131025) does so in its BACKGROUND section, summarizing that same mouse work rather than assaying macrophages itself, so it should not be read as independent confirmation. No specific biochemical/molecular activity has yet been assigned, so only the process and location are captured here.

Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:29131025
    TMEM106a is a conserved type II transmembrane protein which is a key factor to regulate macrophage activation.

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: What is the molecular activity of TMEM106A at the plasma membrane β€” does it function as a receptor, co-receptor, signaling adaptor, or transporter, and what is its physiological ligand?

Q: How mechanistically distinct is TMEM106A from its lysosomal paralog TMEM106B, and to what extent (if any) does TMEM106A also access endolysosomal compartments in specific cell types?

Q: Is the reported tumor-suppressor phenotype a cell-intrinsic consequence of TMEM106A signaling or an indirect effect mediated through macrophage/immune activation in the tumor microenvironment?

Q: Does the Tmem106a locus contribute an out-of-frame C-terminal peptide to a human GSDMD:TMEM106A trans-spliced chimeric mRNA (as shown in mouse), and is that cryptic reading frame regulated or functional independently of the canonical TMEM106A protein?

Suggested Experiments

Experiment: Define the TMEM106A interactome in macrophages with proximity labeling (BioID/TurboID) or co-immunoprecipitation-MS from differentiated macrophages, to move beyond generic binary-interactome hits toward a specific molecular function.

Experiment: Test the requirement of TMEM106A for M1 polarization directly using CRISPR knockout in human macrophages, reading out MAPK and NF-kB pathway activation, surface CD80/CD86/MHC-II, and cytokine output after pro-inflammatory stimulation.

Experiment: Determine subcellular localization at endogenous levels (knock-in tag or validated antibody) with confocal/immuno-EM to test plasma-membrane versus endolysosomal residence and directly address the paralog-derived lysosomal-membrane annotation.

Knowledge Gaps

What is not known β€” curated, literature-grounded statements of the open unknowns (the inverse of core functions).

Gap: The molecular activity of the canonical TMEM106A protein at the plasma membrane is undefined: it is not established whether it acts as a receptor, co-receptor, signaling adaptor, or transporter, and no physiological ligand or validated binding partner is known. The GO annotations capture a process (macrophage activation) and a location (plasma membrane) but no specific molecular function.

OPEN BIOLOGY MF_DARK

What is known: The conserved biological role (positive regulation of macrophage activation / M1 polarization via MAPK and NF-kB) and plasma-membrane localization are supported by the mouse ortholog and human studies; only the biochemical mechanism is dark.

Significance: Without a defined molecular function, TMEM106A cannot be placed mechanistically in the macrophage-activation pathway, and interpretation of its tumor-suppressor phenotype and of any therapeutic targeting remains speculative.

Gap: It is unknown whether the human Tmem106a locus participates in a GSDMD:TMEM106A trans-spliced chimeric mRNA. The chimera, and the out-of-frame C-terminal peptide it contributes, were characterized only in mouse; the existence, regulation, and function of a human orthologue are unestablished.

OPEN BIOLOGY BP_DARK

What is known: In mouse, inflammasome priming upregulates the Gsdmd-Tmem106a chimera and its product cooperates with GSDMD-NT at the plasma membrane; the gap is its conservation and relevance in human.

Significance: A functional human chimera would connect the Tmem106a locus to pyroptosis via a cryptic reading frame, distinct from the canonical TMEM106A macrophage role.

Provenance (the field's own admissions):

πŸ“š Additional Documentation

Notes

(TMEM106A-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)